# BRIDGE-SIC Efficacy Trial

> **NCT07735442** · NA · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 600 (estimated)

## Conditions studied

- Cancer

## Interventions

- **BEHAVIORAL:** LLM-generated SIC summary email to clinical teams

## Key facts

- **NCT ID:** NCT07735442
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-04
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07735442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07735442, "BRIDGE-SIC Efficacy Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07735442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*